Your browser doesn't support javascript.
loading
Glaucoma Knowledge and Disease Severity in a Veteran Population: The Medication Adherence in Glaucoma to Improve Care (MAGIC) Study.
Robinson, Camille G; Schempf, Tadhg; Williams, Andrew M; Muir, Kelly W; Woolson, Sandra; Olsen, Maren; Rosdahl, Jullia A.
Afiliación
  • Robinson CG; School of Medicine, Duke University, Durham, North Carolina.
  • Schempf T; Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Williams AM; Department of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
  • Muir KW; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina; Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina.
  • Woolson S; Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina.
  • Olsen M; Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina.
  • Rosdahl JA; Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina. Electronic address: jullia.rosdahl@duke.edu.
Ophthalmol Glaucoma ; 6(3): 277-282, 2023.
Article en En | MEDLINE | ID: mdl-36400355
ABSTRACT

PURPOSE:

To assess the relationship between glaucoma knowledge and disease severity.

DESIGN:

Substudy of a randomized controlled trial at a single Veterans Affairs (VA) eye clinic.

PARTICIPANTS:

Veterans with medically treated open-angle glaucoma who self-reported poor medication adherence.

METHODS:

Participants completed a glaucoma knowledge assessment using the 10-question National Eye Health Education Program (NEHEP) Eye-Q Test on glaucoma knowledge. Disease severity was determined using visual field criteria. Multiple linear regression was used to assess the association of NEHEP Eye-Q score and disease severity, adjusting for age, number of glaucoma medications, race, sex, and VA Care Assessment Needs (CAN) score. MAIN OUTCOME

MEASURES:

In this cross-sectional, preintervention analysis, the main outcome was glaucoma knowledge as measured by the NEHEP Eye-Q Test.

RESULTS:

Among the 200 study participants, glaucoma severity was mild in 53 (27%), moderate in 56 (28%), severe in 74 (37%), and indeterminant in 17 (9%). The NEHEP Eye-Q scores were low across all severity levels. Scored out of 10, the mean (standard deviation) NEHEP Eye-Q scores were 6.06 (1.57) for mild, 6.21 (1.47) for moderate, 6.28 (1.82) for severe, and 5.88 (1.93) for indeterminate stage. There was no evidence of a significant association between NEHEP scores and disease severity categories (P = 0.78). A regression model did not identify a significant estimated association between NEHEP Eye-Q scores and disease severity after adjusting for age, CAN risk score, number of glaucoma medications, race, and sex.

CONCLUSIONS:

There was no difference in level of glaucoma knowledge based on disease severity. Education-based interventions may benefit patients across all glaucoma stages. FINANCIAL DISCLOSURE(S) The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Veteranos / Glaucoma / Glaucoma de Ángulo Abierto Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Ophthalmol Glaucoma Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Veteranos / Glaucoma / Glaucoma de Ángulo Abierto Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Ophthalmol Glaucoma Año: 2023 Tipo del documento: Article